Skip to main content
. 2009 Sep 26;101(1):22–28. doi: 10.1111/j.1349-7006.2009.01373.x

Table 4.

 Treatment outcomes with second‐line standard dose chemotherapy

Source Design patients n (%) Regimens PFS Duration
McCaffrey et al. ( 56 ) Retrospective 56 VeIP/VIP 23 52 months
Loehrer et al. ( 57 ) Phase II 135 VeIP 24 4.7 years
Motzer et al. ( 61 ) Phase I/II 30 TIP 73 33 months
Kondagunta et al. ( 62 ) Phase II 46 TIP 65 2 years
Mead et al. ( 63 ) Phase II 51 TIP 38 1 year

PSF, progression‐free survival; TIP, paclitaxel, ifosfamide, and cisplatin.